S16 Ep19: Show Me the Data™: Incorporating the Latest Advances in Immunotherapy and EGFR-Targeted Treatments for Resectable Early-Stage NSCLC
Highlights from the PER® CME activity "Show Me the Data™: Incorporating the Latest Advances in Immunotherapy and EGFR-Targeted Treatments for Resectable Early-Stage NSCLC" — this podcast is not certified for credit. To participate in the full accredited activity and earn CME credit, use the link below.
In this podcast, experts Mara Antonoff, MD, FACS; Laura Alder, MD; and Stephanie Worrell, MD, FACS, discuss the latest advances in immunotherapy and EGFR -targeted treatments for patients with resectable, early-stage, non–small cell lung cancer.
Earn CME credit by completing the full accredited…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.